Back
VictoryShares US Value Momentum ETF Vs. Cidara Therapeutics, Inc. Industry Stock Comparison
Sell
47
ULVM
VictoryShares US Value Momentum ETF
Last Price:
$93.00
Seasonality Move:
0.71%
Buy
78
CDTX
Cidara Therapeutics, Inc.
Last Price:
$220.73
Seasonality Move:
11.35%
Sell
47
VictoryShares US Value Momentum ETF (ULVM)
is a Sell
Is VictoryShares US Value Momentum ETF a Buy, Sell or Hold?
-
The current VictoryShares US Value Momentum ETF [ULVM] share price is $91.31. The Score for ULVM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
ULVM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
78
Cidara Therapeutics, Inc. (CDTX)
is a Buy
Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Cidara Therapeutics, Inc. [CDTX] share price is $220.35. The Score for CDTX is 78, which is 56% above its historic median score of 50, and infers lower risk than normal.
-
CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
ULVM Stock Price Chart
What is VictoryShares US Value Momentum ETF's stock price today?
-
The VictoryShares US Value Momentum ETF share price today is $91.31Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ULVM is experiencing selling pressure, which indicates risk of future bearish movement.
CDTX Stock Price Chart
What is Cidara Therapeutics, Inc.'s stock price today?
-
The Cidara Therapeutics, Inc. share price today is $220.35Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight buying pressure.
ULVM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 12.91 | Buy |
| Relative Strength Index (14 RSI): | 52.37 | Buy |
| Chaikin Money Flow: | -1224 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (89.68 - 92.1) | Buy |
| Bollinger Bands (100): | (87.3 - 90.98) | Buy |
CDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 16.79 | Buy |
| Relative Strength Index (14 RSI): | 84.87 | Buy |
| Chaikin Money Flow: | 261741 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (192.91 - 237.53) | Buy |
| Bollinger Bands (100): | (54.69 - 176.45) | Buy |
ULVM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 91.72 | Sell |
| 20-day SMA: | 91.26 | Buy |
| 50-day SMA: | 90.28 | Buy |
| 200-day SMA: | 85.14 | Buy |
| 8-day EMA: | 36.08 | Buy |
| 20-day EMA: | 16.57 | Buy |
| 50-day EMA: | 7.02 | Buy |
| 200-day EMA: | 1.81 | Buy |
CDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 220.19 | Buy |
| 20-day SMA: | 220.08 | Buy |
| 50-day SMA: | 159.67 | Buy |
| 200-day SMA: | 72.77 | Buy |
| 8-day EMA: | 219.95 | Buy |
| 20-day EMA: | 209.45 | Buy |
| 50-day EMA: | 171.39 | Buy |
| 200-day EMA: | 93.26 | Buy |
VictoryShares US Value Momentum ETF Earnings Growth & ULVM Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.
VictoryShares US Value Momentum ETF Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Cidara Therapeutics, Inc. Technical Analysis
| Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||